Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Business

Metabolix winds down biopolymers business

by Michael McCoy
August 1, 2016 | A version of this story appeared in Volume 94, Issue 31

The biobased chemicals company Metabolix will wind down its polyhydroxyalkanoate (PHA) polymers business and focus on its newer business in crop yield improvement. The company says it will immediately eliminate 45 positions, about half of its workforce, and eventually get down to a staff of about 20 people. Metabolix warns that an inability to secure financing for the crop yield business could cause it to liquidate entirely. The firm has struggled since 2012, when Archer Daniels Midland ended a PHA joint venture.

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.